Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate Finance Committee Probes Industry Use Of Educational Grants

This article was originally published in The Pink Sheet Daily

Executive Summary

A letter to 23 companies from committee chair Grassley and ranking member Baucus requests disclosures about policies and financials for educational grants. The committee is exploring whether future guidance or legislation is necessary.

You may also be interested in...



Senate Finance Committee Investigates Propulsid Educational Grants

A July 5 letter to J&J seeks information regarding educational grants connected to Propulsid. The committee is seeking specific dollar amounts paid to certain medical societies and names of employees who evaluated and approved educational grants.

Senate Finance Committee Investigates Propulsid Educational Grants

A July 5 letter to J&J seeks information regarding educational grants connected to Propulsid. The committee is seeking specific dollar amounts paid to certain medical societies and names of employees who evaluated and approved educational grants.

Pfizer Will Monitor Off-Label Drug Use And Report To IG Under Neurontin Settlement

Corporate integrity agreement will be carefully studied in pharmaceutical industry given uncertainties surrounding off-label promotion rules. Pfizer agrees to establish clear policies and keep close tabs on off-label use – but the agreement does not define prohibited or permitted activities.

Topics

UsernamePublicRestriction

Register

LL111799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel